WallStSmart
NVST

Envista Holdings Corp

NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$24.20
+1.01% today

Updated 2026-06-05

Market cap
$4.00B
P/E ratio
60.00
P/S ratio
1.43x
EPS (TTM)
$0.41
Dividend yield
52W range
$18 – $30
Volume
3.1M

Envista Holdings Corp (NVST) Financial statements

SEC filings — annual and quarterly data.

Profit margin
1.73%
Operating margin
8.30%
ROE
2.20%
ROA
3.01%
Debt/equity
0.52x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2015$2.74B$275.50M55.62%12.79%10.07%
2016$2.79B$272.00M57.92%14.46%9.77%
2017$2.81B$301.10M57.90%13.75%10.71%
2018$2.84B$230.70M56.59%10.49%8.11%
2019$2.28B$217.60M59.16%10.32%9.52%
2020$1.93B$33.30M55.63%2.25%1.73%
2021$2.51B$340.50M58.29%12.20%13.57%
2022$2.57B$243.10M57.93%12.42%9.46%
2023$2.57B$-100.20M56.13%1.23%-3.90%
2024$2.51B$-1.12B55.43%-41.35%-44.56%
2025$2.72B$47.00M55.02%8.30%1.73%

Frequently asked questions

What is Envista Holdings Corp's revenue?

Envista Holdings Corp's trailing twelve-month revenue is $2.81B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NVST?

In its most recent fiscal year, NVST ran a gross margin of 55.02%, an operating margin of 8.30%, and a net margin of 1.73%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NVST generate?

NVST produced $230.40M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NVST's balance sheet healthy?

NVST holds $1.21B in cash and equivalents against $1.45B in long-term debt, on $3.11B of shareholder equity. That debt is best read against the cash flow the business throws off each year.